Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Gandhi, Gian ^a   Lydon, Patrick ^b  

^a UNITED NATIONS   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; DISEASE ERADICATION; DRUG COST; ECONOMICS; HEALTH CARE COST; HUMAN; INFECTION CONTROL; METHODOLOGY; PREVENTIVE HEALTH SERVICE; STATISTICS;

COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; DRUG COSTS; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; VACCINES;

EID: 84892667771     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-67     Document Type: Article

References (64)

1. Global Polio Eradication Initiative (GPEI), "About Us," 2010 [Online]. Available: http://www.polioeradication.org/AboutUs.aspx. [Accessed 25 May 2013]
2. Measles-Rubella Initiative (MRI), "About Us," 2012 [Online]. Available: http://www.measlesrubellainitiative.org/learn/about-us/. [Accessed 23 January 2014].
3. Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative. Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S, Vaccine 2003 21 24 3442 3445 10.1016/S0264-410X(03)00347-5 12850356 (Pubitemid 36792100)
4. UNICEF, Elimination of Maternal and Neonatal Tetanus 2013 Available: http://www.unicef.org/health/index-43509.html. [Accessed 25 May 2013]
5. Meningitis Vaccine Project, Our Mission: Eliminating epidemic meningitis in sub-Saharan Africa 2013 Available: http://www.meningvax.org/mission.php. [Accessed 26 May 2013]
6. The Global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Harrison L, Pelton S, Wilder-Smith A, Holst J, Safadi M, Vazquez J, Taha M, LaForce F, von Gottberg A, Borrow R, Plotkin S, Vaccine 2011 29 18 3363 3371 10.1016/j.vaccine.2011.02.058 21376800
7. Yellow Fever Initiative, Providing an opportunity of a lifetime Geneva: WHO-UNICEF 2010 Available: http://www.who.int/csr/disease/yellowfev/YFIbrochure. pdf [Accessed 15 August 2012].
8. Yellow Fever Initiative, One injection, ten years' protection Geneva: WHO 2007 Available: http://www.who.int/csr/disease/yellowfev/yfbooklet-en.pdf. [Accessed 15 August 2012].
9. Disease eradication and health systems development, Morbidity and Mortality weekly Report (MMR). Melgaard B, Creese A, Aylward B, Olivé J-M, Maher C, Supplement - global disease elimination and eradication as public health strategies 1999 48 28 35
10. The principles of disease elimination and eradication. Dowdle WR, Bull world health organ 1998 76 Suppl 2 22 25 10063669 (Pubitemid 128685318)
11. Control, elimination, eradication, and re-emergence of infectious diseases: getting the message right. Heymann D, Bull world health organ 2006 84 2 82 83 10.2471/BLT.05.029512 16501719 (Pubitemid 43275761)
12. UNICEF, UNICEF Supplies & Logistics: Vaccine Price Data 2011 Available: http://www.unicef.org/supply/index-57476.html. [Accessed 15 August 2013]
13. Funding shortfall poses challenge. WHO/UNICEF, Polio Lab Network 2003 IX 2 1 WHO, Geneva. Available: http://apps.who.int/immunization-monitoring/ VolumeIXIssue2June2003.PDF. [Accessed 26 May 2013].
14. UN News Centre, Funding gap threatens response to child measles outbreak in West, Central Africa-UN 2010 Available: http://www.un.org/apps/news/story. asp?Cr=measles&NewsID=34462. [Accessed 25 May 2013]
15. MRI, The Challenges 2012 Available: http://www.measlesrubellainitiative. org/learn/the-challenges/. [Accessed 23 Jan 2014].
16. Goldberg ML, Funding gap threatens progress against polio 2012 Available: http://www.undispatch.com/funding-gap-threatens-progress-against-polio. [Accessed 25 May 2013]
17. GAVI Alliance secretariat, Q&A: New vaccine window decision (GAVI Board meeting, Dhaka, Bangladesh) Geneva: GAVI Alliance 2011
18. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community. Poulos C, Bahl R, Whittington D, Bhan MK, Clemens JD, Acosta CJ, J Health Popul Nutr 2004 22 3 311 321 15609784 (Pubitemid 39585865)
19. Lauria D, Stewart J, Vaccination costs Chapel Hill: Department of environmental sciences and engineering, University of North Carolina (UNC) 2007
20. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia. Touch S, Suraratdecha C, Samnang C, Heng S, Gazley L, Huch C, Sovann L, Chhay C, Soeung S, Vaccine 2010 28 29 4593 4599 10.1016/j.vaccine.2010.04.086 20470803
21. Mass vaccination with two-dose oral cholera vaccine. Legros D, Paquet C, Perea W, Marty I, Mugisha N, Royer H, Neira M, Ivanoff B, Bull World Health Organ 1999 77 10 837 842 10593032
22. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. Thiem V, Hossain M, Son N, Hoa N, Rao M, Canh D, Naficy A, Thi Ke N, Acosta C, Deen J, Clemens J, Trach D, J Health Popul Nutr 2003 21 4 304 308 15043004 (Pubitemid 38332083)
23. The World Bank, Inflation, GDP deflator 2013 Available: http://data.worldbank.org/indicator/NY.GDP.DEFL.KD.ZG. [Accessed 04 October 2013]
24. OANDA Corporation, Historical Exchange Rates," OANDA Corporation 2013 Available: http://www.oanda.com/currency/historical-rates/. [Accessed 26 May 2013]
25. The Costs of future polio risk management policies. Duintjer Tebbens R, Sangrujee N, Thompson K, Risk Anal 2006 26 6 1507 1531 Table A3 10.1111/j.1539-6924.2006.00842.x 17184394 (Pubitemid 44952472)
26. WHO, Definition of Region Groupings 2013 Available: http://www.who.int/ healthinfo/global-burden-disease/definition-regions/en/. [Accessed 25 May 2013]
27. GAVI Alliance Secretariat, Vaccine investment strategy 2013 Available: http://www.gavialliance.org/about/strategy/vaccine-investment-strategy/. [Accessed 30 May 2013]
28. GAVI Alliance Secretariat, GAVI Alliance vaccine introduction grant and operational support for campaigns policy 2012 Available: http://www. gavialliance.org/library/gavi-documents/policies/gavi-alliance-vaccine- introduction-grants-and-operational-support-for-campaigns-policy/. [Accessed 2013 June 10]
29. WHO-UNICEF, WHO-UNICEF Guidelines for developing a comprehensive multi-year plan (WHO/IVB/05.20) Geneva: WHO 2006
30. United Nations, Department of economic and social affairs, population division. World population prospects, The 2010 Revision New York: UN Population Division 2011
31. WHO and UNICEF estimates of national immunization coverage, 2012 revision (completed July 2013) Geneva: WHO/UNICEF 2013
32. GAVI Alliance Secretariat, GAVI Alliance new vaccine support application form Geneva: GAVI Secretariat 2012
33. Economic evaluation of measles catch-up and follow-up campaigns in Afghanistan in 2002 and 2003. Vijayaraghavan M, Lievano F, Cairns L, Wolfson L, Nandy R, Ansari A, Golaz A, Mashal T, Salama P, Disasters 2006 30 2 256 269 10.1111/j.0361-3666.2006.00318.x 16689921 (Pubitemid 43676943)
34. Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Dayan G, Cairns L, Sangrujee N, Mtonga A, Nguyen V, Strebel P, Vaccine 2004 22 3-4 475 484 14670330 (Pubitemid 37510279)
35. Lydon P, Costing of measles campaigns, West Pacific Region: The Lao PDR Measles Campaigns, 2000-2001 Geneva: WHO 2001
36. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda. Bishai D, Johns B, Nair D, Nabyonga-Orem J, Fiona-Makmot B, Simons E, Dabbagh A, J Infect Dis 2011 204 Suppl 1 107 S115 21666151
37. Lydon P, Costing of Measles Campaigns, Africa Region: The Tanzania Measles Campaign, 23-24 September 2000 Geneva: WHO 2001
38. The cost of child health days: a case study of Ethiopia's enhanced outreach strategy (EOS). Fiedler J, Chuko T, Health Policy Plan 2008 23 4 222 233 10.1093/heapol/czn015 18562457 (Pubitemid 351882000)
39. Impact of mass measles campaigns among children less than 5 years Old in Uganda. Nanyunja M, Lewis R, Makumbi I, Seruyange R, Kabwongera E, Mugyenyi P, Talisuna A, J Infect Dis 2003 187 Supplement 1 63 S68 12721893
40. Cost of polio immunization days in china: implications for mass immunization campaign strategies. Jian Z, Jing-Jin Y, Rong-Zhen Z, Xing-Lu Z, Jun Z, Wing J, Schnur A, Ke-An W, Int J Health Plann Manage 1998 13 5 25 10.1002/(SICI)1099-1751(199801/03)13:1<5::AID-HPM497>3.0.CO;2-8 10178584 (Pubitemid 28174752)
41. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Griffiths U, Wolfson L, Quddus A, Younus M, Hafiz R, Bull World Health Organ 2004 82 9 643 651 15628201 (Pubitemid 39278539)
42. Coûts de la riposte vaccinale contre la fièvre jaune à Abidjan, 2001. Zengbe-Acray P, Douba A, Traore Y, Dagnan S, Attoh-Toure H, Ekra D, Sante Publique 2009 21 4 383 391 20101817
43. Évaluation des coûts opérationnels d'une campagne de masse préventive contre la méningite à méningocoque et la fièvre jaune au Sénégal, en 1997. da Silva A, Parent du Châtelet I, Gaye A, Dompnier J-P, Seck I, Sante 2003 13 4 215 223 15047438 (Pubitemid 38297844)
44. Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Colombini A, Badolo O, Gessner B, Jaillard P, Seini E, Da Silva A, Vaccine 2011 29 33 5474 5480 10.1016/j.vaccine.2011.05.058 21641952
45. Meningitis outbreaks and vaccination strategy. Varaine F, Caugant D, Riou J, Kondé M, Soga G, Nshimirimana D, Muhirwa G, Ott D, Høiby E, Fermon F, Moren A, Trans R Soc Trop Med Hyg 1997 91 1 3 7 10.1016/S0035-9203(97) 90371-0 9093614 (Pubitemid 27095486)
46. Priority during a meningitis epidemic: Vaccination or treatment? Veeken H, Ritmeijer K, Hausman B, Bull World Health Organ 1998 73 2 135 141 (Pubitemid 28305225)
47. Variation in the costs of delivering routine immunization services in Peru. Walker D, Mosquiera N, Penny M, Lanata C, Clark A, Sanderson C, et al. Bull World Health Organ 2004 82 9 676 682 15628205 (Pubitemid 39278543)
48. WHO, UNICEF, UNFPA, Maternal and neonatal tetanus elimination by 2005: Strategies for achieving and maintaining elimination [WHO/V&B/02.09] Geneva: WHO 2000
49. Søreide T, Tostensen A, Skage I, Hunting for Per Diem The Uses and Abuses of Travel Compensation in Three Developing Countries-Report 2/2012 Study Oslo: Norwegian Agency for Development Cooperation (Norad) Evaluation Department 2012
50. WHO, Retrospective Measles Data on Supplementary Immunization Activities 2000-2012 2013 Available: http://www.who.int/entity/immunization/monitoring- surveillance/data/Summary-Measles-SIAs-2000-2012.xls
51. World Health Organization Regional Office for Europe (WHO-EURO), Field Guide For Planning and Implementing Supplementary Immunization Activities for Measles and Rubella Copenhagen: WHO EURO 2004
52. WHO International Coordinating Group (ICG) for Meningitis Vaccine Provision, Outbreak of Meningococcal Meningitis Application Form (ANNEX 5): Estimation of Operational Costs Geneva: WHO 2010
53. Perceptions of per diems in the health sector: evidence and implications. Vian T, Miller C, Themba Z, Bukuluki P, Health Policy Plan 2013 28 3 237 246 10.1093/heapol/czs056 22684639
54. GPEI, Polio Eradication and Endgame Strategic Plan 2013-2018 Geneva: WHO 2013
55. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities. Fields R, Dabbagh A, Jain M, Sagar K, Vaccine 2013 31S Supplement 2 115 B121
56. Performance and determinants of routine immunization coverage within the context of intensive polio eradication activities in Uttar Pradesh, India: Social Mobilization Network (SM Net) and Core Group Polio Project (CGPP). Weiss W, Choudhary M, Solomon R, BMC International Health and Human Rights 2013 13 25
57. Attitudes and Practices of Auxiliary Nurse Midwives and Accredited Social Health Activists in Uttar Pradesh and Bihar Regarding Polio Immunization in India. Thacker N, Choudhury P, Gargano L, Weiss P, Pazol K, Vashishtha V, Bahl S, Jafari H, Kumar A, Arora M, Venczel L, Orenstein W, Omer S, Hughes J, Journal of Tropical Pediatrics 2013 59 4 266 273 10.1093/tropej/fmt008 23436233
58. What must be done about the killings of Pakistani healthcare workers? Bhutta Z, British Medical Journal (BMJ) 2013 346 280
59. Killings Force Rethinking of Pakistan's Anti-Polio Drive. Roberts L, Science 2013 339 6117 259 260 10.1126/science.339.6117.259 23329023
60. Eradication versus control: the economics of global infectious disease policies. Barrett S, Bull World Health Organ 2004 82 9 683 688 15628206 (Pubitemid 39278544)
61. GAVI Alliance Secretariat, GAVI Standard Operating Procedure: Countries' GAVI eligibility status for 2012 Geneva: GAVI Alliance 2011
62. Global vaccine action plan. Decade of Vaccines Collaboration, Vaccine 2013 31 Supplement 2 5 B31 23734366
63. Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries. Kamara L, Lydon P, Bilous J, Vandelaer J, Eggers R, Gacic-Dobo M, Meany W, Okwo-Bele J-M, Health Policy Plan 2013 28 1 11 19 10.1093/heapol/czs020 22411879
64. GPEI, Financial Resource Requirements 2011-2012: As of October 2011 Geneva: WHO 2011